Jean-Marie Eveillard - First Eagle Investment Management,
Holding/activity history for Vanda Pharmaceuticals Inc (VNDA)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2013 Q3 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2013 Q2 | 975,000 | 0.03 | Reduce 48.99% | 0.01 | $8.08 | $7,878,000 | SEC |
| 2013 Q1 | 1,911,452 | 0.03 | $3.92 | $7,493,000 | SEC | ||
| 2012 Q4 | 1,911,452 | 0.03 | Add 43.16% | <0.01 | $3.70 | $7,072,000 | SEC |
| 2012 Q3 | 1,335,152 | 0.03 | Add 5.57% | <0.01 | $4.03 | $5,381,000 | SEC |
| 2012 Q2 | 1,264,752 | 0.03 | Add 15.96% | <0.01 | $4.40 | $5,565,000 | SEC |
| 2012 Q1 | 1,090,633 | 0.03 | Add 2.83% | <0.01 | $4.79 | $5,224,000 | SEC |
| 2011 Q4 | 1,060,633 | 0.03 | Add 11.05% | <0.01 | $4.76 | $5,049,000 | SEC |
| 2011 Q3 | 955,100 | 0.03 | Add 7.92% | <0.01 | $4.95 | $4,728,000 | SEC |
| 2011 Q2 | 885,000 | 0.04 | $7.14 | $6,319,000 | SEC | ||
| 2011 Q1 | 885,000 | 0.04 | Add 7.01% | <0.01 | $7.29 | $6,452,000 | SEC |
| 2010 Q4 | 827,000 | 0.03 | Add 0.24% | <0.01 | $9.46 | $7,823,000 | SEC |
| 2010 Q3 | 825,000 | 0.05 | Add 17.02% | <0.01 | $6.68 | $5,511,000 | SEC |
| 2010 Q2 | 705,000 | 0.05 | Buy | 0.05 | $6.61 | $4,660,000 | SEC |
| 2010 Q1 | 0 | 0.00 | Sell 100.00% | 0.06 | SEC | ||
| 2009 Q4 | 356,375 | 0.06 | Buy | 0.06 | $12.85 | $4,579,000 | SEC |
| 2009 Q2 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2009 Q1 | 123,200 | <0.01 | $0.90 | $111,000 | SEC | ||
| 2008 Q4 | 123,200 | <0.01 | Add 39.68% | <0.01 | $0.51 | $63,000 | SEC |
| 2008 Q3 | 88,200 | <0.01 | Reduce 14.37% | <0.01 | $0.98 | $86,000 | SEC |
| 2008 Q2 | 103,000 | <0.01 | Reduce 1.90% | <0.01 | $3.29 | $339,000 | SEC |
| 2008 Q1 | 105,000 | 0.01 | Add 162.50% | <0.01 | $3.87 | $406,000 | SEC |
| 2007 Q4 | 40,000 | <0.01 | Add 60.00% | <0.01 | $6.88 | $275,000 | SEC |
| 2007 Q3 | 25,000 | <0.01 | Reduce 50.00% | <0.01 | $13.92 | $348,000 | SEC |
| 2007 Q2 | 50,000 | 0.01 | Buy | 0.01 | $20.26 | $1,013,000 | SEC |